Literature DB >> 31704437

Protocol for a systematically-developed, phase I/II, single-blind randomized controlled trial of treadmill walking exercise training effects on cognition and brain function in persons with multiple sclerosis.

Brian M Sandroff1, M David Diggs2, Marcas M Bamman3, Gary R Cutter4, Jessica F Baird2, C Danielle Jones2, John R Rinker5, Glenn R Wylie6, John DeLuca6, Robert W Motl2.   

Abstract

Slowed cognitive processing speed (CPS) is a common and debilitating consequence of multiple sclerosis (MS) that is notoriously difficult to treat. As such, we undertook a systematic line of research that indicated that supervised, progressive treadmill walking exercise (TMWX) training might improve CPS and brain functioning among fully-ambulatory persons with MS. The current study will be the first adequately-powered, single-blind randomized controlled trial (RCT) that examines the efficacy of 12-weeks of TMWX training compared with an active control condition on CPS, thalamocortical brain connectivity (based on resting-state fMRI), and exploratory functional outcomes in 88 fully-ambulatory persons with MS who present with slowed CPS. The intervention condition involves supervised, progressive TMWX training 3 times/week over 12-weeks; this initially involves 15-min of light-to-moderate intensity TMWX that progresses up to 40-min of vigorous intensity TMWX. The active control condition involves supervised, minimal intensity, stretching-and-resistance exercise that will be delivered on the same frequency as the intervention condition. The primary study outcomes involve Symbol Digit Modalities Test performance (i.e., CPS) and fMRI-based measures of thalamocortical resting-state functional connectivity. Exploratory study outcomes involve measures of community participation, activities of daily living, quality of life, and functional mobility. All study outcomes will be administered before and after the 12-week study period by treatment-blinded assessors. If successful, the current study will provide the first Class I evidence for the effects of TMWX training as an approach for improving CPS and its neural correlate, and possibly mitigating the impact of slowed CPS on functional outcomes in MS.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain; Cognition; Exercise; Multiple sclerosis; Walking

Year:  2019        PMID: 31704437      PMCID: PMC6875638          DOI: 10.1016/j.cct.2019.105878

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  61 in total

1.  Multimodal exercise training in multiple sclerosis: A randomized controlled trial in persons with substantial mobility disability.

Authors:  Brian M Sandroff; Rachel E Bollaert; Lara A Pilutti; Melissa L Peterson; Tracy Baynard; Bo Fernhall; Edward McAuley; Robert W Motl
Journal:  Contemp Clin Trials       Date:  2017-07-19       Impact factor: 2.226

2.  Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial.

Authors:  A Carter; A Daley; L Humphreys; N Snowdon; N Woodroofe; J Petty; A Roalfe; J Tosh; B Sharrack; J M Saxton
Journal:  Mult Scler       Date:  2014-01-13       Impact factor: 6.312

3.  Assessing mobility in older adults: the UAB Study of Aging Life-Space Assessment.

Authors:  Claire Peel; Patricia Sawyer Baker; David L Roth; Cynthia J Brown; Eric V Brodner; Richard M Allman
Journal:  Phys Ther       Date:  2005-10

4.  High-intensity interval exercise improves cognitive performance and reduces matrix metalloproteinases-2 serum levels in persons with multiple sclerosis: A randomized controlled trial.

Authors:  Philipp Zimmer; Wilhelm Bloch; Alexander Schenk; Max Oberste; Stefan Riedel; Jan Kool; Dawn Langdon; Ulrik Dalgas; Jürg Kesselring; Jens Bansi
Journal:  Mult Scler       Date:  2017-08-21       Impact factor: 6.312

Review 5.  Cognitive dysfunction and multiple sclerosis: developing a rationale for considering the efficacy of exercise training.

Authors:  Robert W Motl; Brian M Sandroff; Ralph H B Benedict
Journal:  Mult Scler       Date:  2011-06-17       Impact factor: 6.312

6.  Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline.

Authors:  Sarah A Morrow; Allison Drake; Robert Zivadinov; Frederick Munschauer; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  Clin Neuropsychol       Date:  2010-09-08       Impact factor: 3.535

7.  Fitness and cognitive processing speed in persons with multiple sclerosis: a cross-sectional investigation.

Authors:  Brian M Sandroff; Robert W Motl
Journal:  J Clin Exp Neuropsychol       Date:  2012-08-21       Impact factor: 2.475

8.  Longitudinal variations and predictors of increased perceived impact of multiple sclerosis, a two-year study.

Authors:  Charlotte Ytterberg; Sverker Johansson; Lotta Widén Holmqvist; Lena von Koch
Journal:  J Neurol Sci       Date:  2008-03-04       Impact factor: 3.181

9.  Short-term interval aerobic exercise training does not improve memory functioning in relapsing-remitting multiple sclerosis-a randomized controlled trial.

Authors:  Lisa Baquet; Helge Hasselmann; Stefan Patra; Jan-Patrick Stellmann; Eik Vettorazzi; Andreas K Engel; Sina Cathérine Rosenkranz; Jana Poettgen; Stefan Michael Gold; Karl-Heinz Schulz; Christoph Heesen
Journal:  PeerJ       Date:  2018-12-12       Impact factor: 2.984

10.  Rationale and design of a single-blind, randomised controlled trial of exercise training for managing learning and memory impairment in persons with multiple sclerosis.

Authors:  Brian M Sandroff; Robert W Motl; Marcus Bamman; Gary R Cutter; Mark Bolding; John R Rinker; Glenn R Wylie; Helen Genova; John DeLuca
Journal:  BMJ Open       Date:  2018-12-14       Impact factor: 2.692

View more
  4 in total

1.  Thalamic atrophy moderates associations among aerobic fitness, cognitive processing speed, and walking endurance in persons with multiple sclerosis.

Authors:  Brian M Sandroff; Robert W Motl; Cristina A F Román; Glenn R Wylie; John DeLuca; Gary R Cutter; Ralph H B Benedict; Michael G Dwyer; Robert Zivadinov
Journal:  J Neurol       Date:  2022-06-19       Impact factor: 6.682

2.  Aerobic reserve capacity in multiple sclerosis-Preliminary evidence.

Authors:  Corey D Feasel; Brian M Sandroff; Robert W Motl
Journal:  Acta Neurol Scand       Date:  2021-04-29       Impact factor: 3.915

3.  Cognitive Impairment Impacts Exercise Effects on Cognition in Multiple Sclerosis.

Authors:  Annette Rademacher; Niklas Joisten; Sebastian Proschinger; Wilhelm Bloch; Roman Gonzenbach; Jan Kool; Dawn Langdon; Jens Bansi; Philipp Zimmer
Journal:  Front Neurol       Date:  2021-01-28       Impact factor: 4.003

Review 4.  Treatment and management of cognitive dysfunction in patients with multiple sclerosis.

Authors:  John DeLuca; Nancy D Chiaravalloti; Brian M Sandroff
Journal:  Nat Rev Neurol       Date:  2020-05-05       Impact factor: 42.937

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.